Huisheng Oral Solution Adjunct With Platinum-Based Chemotherapy for the Treatment of Advanced Non–Small Cell Lung Cancer: A Meta-Analysis and Systematic Review

BACKGROUND: Platinum-based chemotherapy is one of the first line therapies for the advanced non–small cell lung cancer (NSCLC), even though its high toxicity and limited clinical effects cannot be neglected. Huisheng oral solution (HSOS) has been widely used as an adjuvant chemotherapy drug for NSCL...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Jingyi, Wang, Zhichao, Xue, Han, Cao, Ailing, Turner, Cassidy, Wang, Jing, Zhang, Li, Wang, Jinghai, Xiao, Na, Xu, Jie, Zhou, Xianmei, He, Hailang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7508161/
https://www.ncbi.nlm.nih.gov/pubmed/33013377
http://dx.doi.org/10.3389/fphar.2020.476165

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7508161/
https://www.ncbi.nlm.nih.gov/pubmed/33013377
http://dx.doi.org/10.3389/fphar.2020.476165

Ejemplares similares